Qu Biologics: Seniors in Metro Vancouver Invited to Participate in a

Vancouver, BC, June 07, 2024 (GLOBE NEWSWIRE) - Qu Biologics Inc., a Burnaby-based clinical-stage biotechnology company, is pleased to announce that the RESILIENCE Study, a clinical trial evaluating a new immunomodulator designed to strengthen natural immunity among seniors aged 65 or older, is enrolling participants in the study. Why are we conducting this study?As we [...]